Does the Glucagon-like Peptide-1 Receptor Agonist Semaglutide Prevent Deterioration of Metabolic State in Prediabetic or Diabetic Patients With Schizophrenia Treated With the Antipsychotic Compounds Clozapine or Olanzapine?
Latest Information Update: 16 Jul 2024
At a glance
- Drugs Semaglutide (Primary) ; Clozapine; Olanzapine
- Indications Schizophrenia; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Jul 2024 Planned primary completion date changed from 1 Jul 2024 to 1 Sep 2024.
- 03 Jul 2024 Status changed from recruiting to active, no longer recruiting.
- 06 Oct 2023 Planned primary completion date changed from 30 Sep 2024 to 1 Jul 2024.